Fox Run Management, L.L.C. Bio Techne Corp Transaction History

Fox Run Management, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$62.12 - $84.15 $1.02 Million - $1.38 Million	16,449 New	16,449 $1.18 Million
Q3 2023 Nov 07, 2023	BUY	$67.52 - $89.42 $398,232 - $527,399	5,898 New	5,898 $401,000
Q1 2023 May 12, 2023	BUY	$71.62 - $86.62 $872,546 - $1.06 Million	12,183 Added 261.55%	16,841 $1.25 Million
Q4 2022 Feb 07, 2023	BUY	$80.67 - $352.29 $375,760 - $1.64 Million	4,658 New	4,658 $386,000

601

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.8B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.